Published peptide research references
Cotadutide
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
DOI: 10.1038/s42255-020-0209-6PMID: 32478287
Source identity and connection checked by Codex (AI).
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease.
Selvarajah V, Robertson D, Hansen L, Jermutus L, Smith K, Coggi A, Sánchez J, Chang YT, Yu H, Parkinson J, Khan A, Chung HS, Hess S, Dumas R, Duck T, Jolly S, Elliott TG, Baker J, Lecube A, Derwahl KM, Scott R, Morales C, Peters C, Goldenberg R, Parker VER, Heerspink HJL, study investigators · Kidney international · 2024
DOI: 10.1016/j.kint.2024.08.023PMID: 39218393
Source identity and connection checked by Codex (AI).
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes.
Parker VER, Robertson D, Erazo-Tapia E, Havekes B, Phielix E, de Ligt M, Roumans KHM, Mevenkamp J, Sjoberg F, Schrauwen-Hinderling VB, Johansson E, Chang YT, Esterline R, Smith K, Wilkinson DJ, Hansen L, Johansson L, Ambery P, Jermutus L, Schrauwen P · Nature metabolism · 2023
DOI: 10.1038/s42255-023-00938-0PMID: 38066113
Source identity and connection checked by Codex (AI).
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study.
Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P · Diabetes care · 2021
DOI: 10.2337/dc20-2151PMID: 34016612
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Selvarajah V
- Robertson D
- Hansen L
- Jermutus L
- Smith K
- Coggi A
- Sánchez J
- Chang YT
- Yu H
- Parkinson J
- Khan A
- Chung HS
- Hess S
- Dumas R
- Duck T
- Jolly S
- Elliott TG
- Baker J
- Lecube A
- Derwahl KM
- Scott R
- Morales C
- Peters C
- Goldenberg R
- Parker VER
- Heerspink HJL
- study investigators
- Erazo-Tapia E
- Havekes B
- Phielix E
- de Ligt M
- Roumans KHM
- Mevenkamp J
- Sjoberg F
- Schrauwen-Hinderling VB
- Johansson E
- Esterline R
- Wilkinson DJ
- Johansson L
- Ambery P
- Schrauwen P
- Nahra R
- Wang T
- Gadde KM
- Oscarsson J
- Stumvoll M
- Hirshberg B
- Boland ML
- Laker RC
- Mather K
- Nawrocki A
- Oldham S
- Boland BB
- Lewis H
- Conway J
- Naylor J
- Guionaud S
- Feigh M
- Veidal SS
- Lantier L
- McGuinness OP
- Grimsby J
- Rondinone CM
- Larsen MR
- Trevaskis JL
- Rhodes CJ